Teachers Retirement System of The State of Kentucky Buys Shares of 454,700 Smith & Nephew SNATS, Inc. $SNN

Teachers Retirement System of The State of Kentucky purchased a new stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 454,700 shares of the medical equipment provider’s stock, valued at approximately $16,501,000.

Other institutional investors have also recently made changes to their positions in the company. Bank of Montreal Can grew its holdings in shares of Smith & Nephew SNATS by 321.6% during the 2nd quarter. Bank of Montreal Can now owns 3,429,829 shares of the medical equipment provider’s stock worth $105,056,000 after purchasing an additional 2,616,301 shares during the period. JPMorgan Chase & Co. lifted its position in Smith & Nephew SNATS by 6,663.4% in the second quarter. JPMorgan Chase & Co. now owns 1,210,655 shares of the medical equipment provider’s stock valued at $37,082,000 after buying an additional 1,192,755 shares during the last quarter. ABC Arbitrage SA boosted its stake in Smith & Nephew SNATS by 1,063.4% during the second quarter. ABC Arbitrage SA now owns 898,635 shares of the medical equipment provider’s stock worth $27,525,000 after buying an additional 821,393 shares during the period. Todd Asset Management LLC acquired a new stake in shares of Smith & Nephew SNATS during the third quarter valued at about $26,319,000. Finally, Goldman Sachs Group Inc. increased its position in shares of Smith & Nephew SNATS by 49.2% during the first quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider’s stock valued at $50,255,000 after acquiring an additional 583,809 shares during the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew SNATS Stock Performance

Shares of SNN stock opened at $36.72 on Wednesday. The firm has a 50 day moving average of $34.29 and a two-hundred day moving average of $34.94. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40. Smith & Nephew SNATS, Inc. has a 52 week low of $23.91 and a 52 week high of $38.79.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Canaccord Genuity Group lowered their price objective on shares of Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating for the company in a research report on Tuesday, November 11th. Royal Bank Of Canada lowered Smith & Nephew SNATS from an “outperform” rating to a “sector perform” rating in a research report on Monday, December 15th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research note on Wednesday, January 21st. Wall Street Zen lowered Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Finally, Kepler Capital Markets upgraded Smith & Nephew SNATS to a “strong-buy” rating in a report on Monday, November 17th. One equities research analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $35.75.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.